Mercadal L, Tezenas du Montcel S, Chonchol MB, Debure A, Depreneuf H, Servais A, Bassilios N, Assogba U, Allouache M, Prie D
The results demonstrated that febuxostat was linked to a significantly reduced risk of the primary composite endpoint, encompassing cerebral, cardiovascular, renal events, and all-cause mortality
When cysteine is limiting, we found that GCLC instead ligates glutamate to alternative amino acids to prevent the toxic accumulation of glutamate and ROS generation
Moreover, it has been observed that cyclic GSH, which is less sensitive to the effects of several degradative enzymes, appears to have toxic activity on cancer cell lines 87
doi: 10.1055/s-0042-110491 30 WertenbruchTWillenbergHSSagertCNguyenTBBahloMFeldkampJet al
Fernandes Gomes B, Kumar A, Ashton NJ et al (2024) Corticotropin-releasing hormone as a candidate biomarker for parkinsonian disorders